Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -100.35% is in line with its 5-year average of -97.42%, near the high end of its 5-year range (-1156.98%–35.99%).
As of the fiscal period ended Tuesday, June 30, 2026. 177.92% below its 12-month average of -36.11%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -100.35%.
RETURN ON INVESTED CAPITAL (ROIC)
-100.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-36.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-257.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-97.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-76.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-177.92%
CURRENT VS 3Y AVG
+61.07%
CURRENT VS 5Y AVG
-3.00%
CURRENT VS 10Y AVG
-31.11%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.88%
median of 495 covered companies
CURRENT VS SECTOR MEDIAN
-247.46%
vs the sector median at left
Atara Biotherapeutics, Inc.
Market Cap
$84.79M
Return on Invested Capital (ROIC)
-100.35%
TTM Avg
-36.11%
3Y Avg
-257.73%
5Y Avg
-97.42%
Market Cap
$84.13M
Return on Invested Capital (ROIC)
-109.43%
TTM Avg
-208.02%
3Y Avg
-178.83%
5Y Avg
-203.50%
Market Cap
$84.17M
Return on Invested Capital (ROIC)
-90.27%
TTM Avg
-103.33%
3Y Avg
-85.38%
5Y Avg
-72.83%
Market Cap
$85.60M
Return on Invested Capital (ROIC)
-88.28%
TTM Avg
-61.59%
3Y Avg
-48.92%
5Y Avg
-67.61%
Market Cap
$87.88M
Return on Invested Capital (ROIC)
-34.10%
TTM Avg
-61.58%
3Y Avg
-76.39%
5Y Avg
-65.18%
Market Cap
$87.96M
Return on Invested Capital (ROIC)
12.79%
TTM Avg
17.38%
3Y Avg
-11.40%
5Y Avg
-8.36%
Market Cap
$88.21M
Return on Invested Capital (ROIC)
8.16%
TTM Avg
0.11%
3Y Avg
-4.79%
5Y Avg
-3.69%
Market Cap
$88.63M
Return on Invested Capital (ROIC)
-159.30%
TTM Avg
-82.85%
3Y Avg
-66.58%
5Y Avg
-50.22%
Market Cap
$88.97M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | $84.79M | -100.35% | -36.11% | -257.73% | -97.42% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | -109.43% | -208.02% | -178.83% | -203.50% |
| Humacyte, Inc. (HUMA)vs › | $84.17M | -90.27% | -103.33% | -85.38% | -72.83% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $85.60M | -88.28% | -61.59% | -48.92% | -67.61% |
| Equillium, Inc. (EQ)vs › | $87.88M | -34.10% | -61.58% | -76.39% | -65.18% |
| CareCloud, Inc. (CCLD)vs › | $87.96M | 12.79% | 17.38% | -11.40% | -8.36% |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 8.16% | 0.11% | -4.79% | -3.69% |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | -159.30% | -82.85% | -66.58% | -50.22% |
| Conexeu Sciences Inc. (CNXU)vs › | $88.97M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $79.78M | -88.72% | -42.77% | -39.33% | -39.33% |
ROIC
-100.3%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -100.35% |
| 2026-03-31 | -43.96% |
| 2025-06-30 | 35.99% |
| 2025-03-31 | -94.65% |
| 2023-12-31 | -1156.98% |
| 2023-09-30 | -265.80% |
| 2023-06-30 | -178.37% |
| 2023-03-31 | -114.13% |
| 2022-12-31 | -94.29% |
| 2022-09-30 | -100.78% |
| 2022-06-30 | -80.60% |
| 2022-03-31 | -118.50% |
| 2021-12-31 | -93.96% |
| 2021-09-30 | -90.37% |
| 2021-06-30 | -86.60% |
| 2021-03-31 | -70.18% |
| 2020-12-31 | -61.17% |
| 2020-09-30 | -83.11% |
| 2020-06-30 | -76.91% |
| 2020-03-31 | -112.86% |
| 2019-12-31 | -96.56% |
| 2019-09-30 | -89.14% |
| 2019-06-30 | -114.95% |
| 2019-03-31 | -87.65% |
| 2018-12-31 | -67.39% |
| 2018-09-30 | -45.94% |
| 2018-06-30 | -34.92% |
| 2018-03-31 | -30.49% |
| 2017-12-31 | -63.92% |
| 2017-09-30 | -49.01% |
| 2017-06-30 | -42.45% |
| 2017-03-31 | -38.62% |
| 2016-12-31 | -31.95% |
| 2016-09-30 | -31.12% |
| 2016-06-30 | -24.27% |
| 2016-03-31 | -21.77% |
| 2015-12-31 | -18.54% |
| 2015-09-30 | -14.16% |
| 2015-06-30 | -27.41% |
| 2015-03-31 | -18.27% |
| 2014-12-31 | -27.23% |
| 2014-09-30 | -40.57% |
| 2014-06-30 | -31.17% |
| 2014-03-31 | -23.98% |
| 2013-12-31 | -17.13% |
